Citadel Advisors
PRVA icon

Citadel Advisors’s Privia Health PRVA Stock Holding History

Citadel Advisors’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Sell
48,835
-441,578
-90% -$10.2M ﹤0.01% 7646
2026
Q1 		$10.1M Sell
490,413
-251,769
-34% -$5.67M ﹤0.01% 3240
2025
Q4 		$17.6M Buy
742,182
+703,248
+1,806% +$17.1M ﹤0.01% 2510
2025
Q3 		$969K Sell
38,934
-467,233
-92% -$10.1M ﹤0.01% 7597
2025
Q2 		$11.6M Sell
506,167
-40,641
-7% -$941K ﹤0.01% 2813
2025
Q1 		$12.3M Buy
546,808
+201,300
+58% +$4.68M ﹤0.01% 2597
2024
Q4 		$6.75M Buy
345,508
+47,675
+16% +$945K ﹤0.01% 3508
2024
Q3 		$5.42M Sell
297,833
-5,040
-2% -$96.2K ﹤0.01% 3806
2024
Q2 		$5.26M Sell
302,873
-119,279
-28% -$2.11M ﹤0.01% 3673
2024
Q1 		$8.27M Buy
+422,152
New +$8.92M ﹤0.01% 3178
2023
Q4 		– Sell
-14,266
Closed -$319K – 15023
2023
Q3 		$328K Buy
+14,266
New +$363K ﹤0.01% 8994
2023
Q2 		– Sell
-196,299
Closed -$5.18M – 15049
2023
Q1 		$5.42M Buy
196,299
+108,761
+124% +$2.87M ﹤0.01% 3677
2022
Q4 		$1.99M Sell
87,538
-861,740
-91% -$24M ﹤0.01% 5501
2022
Q3 		$32.3M Buy
949,278
+899,331
+1,801% +$33.3M 0.01% 1409
2022
Q2 		$1.46M Sell
49,947
-362,594
-88% -$9.22M ﹤0.01% 6193
2022
Q1 		$11M Buy
412,541
+128,799
+45% +$3.04M ﹤0.01% 2805
2021
Q4 		$7.34M Buy
283,742
+117,352
+71% +$2.93M ﹤0.01% 3626
2021
Q3 		$3.92M Sell
166,390
-99,975
-38% -$3.49M ﹤0.01% 4796
2021
Q2 		$11.8M Buy
+266,365
New +$9.83M ﹤0.01% 2820

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Citadel Advisors's PRVA Position: Q2 2026 in Review

Citadel Advisors reduced its Privia Health (PRVA) stake by 90% in Q2 2026, selling an estimated $10.2M and leaving 48,835 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #7646.

Citadel Advisors first reported a position in PRVA in Q2 2021 and has held it in 19 quarters since. The position peaked at $32.3M in Q3 2022. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Citadel Advisors held 48,835 shares of Privia Health worth $1.26M as of Q2 2026.
  • Citadel Advisors sold 441,578 Privia Health shares in Q2 2026, an estimated $10.2M.
  • Privia Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #7646 holding.
  • Citadel Advisors first reported a position in Privia Health in Q2 2021 and has held it in 19 quarters since.
  • Citadel Advisors's Privia Health position peaked at $32.3M in Q3 2022.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.